Nimble Therapeutics spins out of Roche to focus on peptide R&DUS biotech Nimble Therapeutics has announced it is operating as a standalone business after spinning out from Roche, Share XNimble Therapeutics spins out of Roche to focus on peptide R&Dhttps://pharmaphorum.com/news/nimble-therapeutics-spins-out-of-roche-to-focus-on-peptide-rd/
